Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy. [electronic resource]
Producer: 20191108Description: 1376-1389 p. digitalISSN:- 2159-8290
- Animals
- Antibiotics, Antineoplastic -- pharmacology
- Daunorubicin -- pharmacology
- Drug Resistance, Neoplasm
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Polycomb Repressive Complex 2 -- antagonists & inhibitors
- Proto-Oncogene Proteins c-mdm2 -- antagonists & inhibitors
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53 -- genetics
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.